WAKEFIELD, Mass.--(BUSINESS WIRE)--Implant Sciences Corporation (AMEX: IMX) a developer and manufacturer of products for national security, medicine and industry, today announced that a Fortune-500 provider of technology-based products and services has awarded Implant’s semiconductor division a service contract expected to run over the next twenty-four (24) months with the potential to generate revenues of up to $1.5 million. The Company has received the first purchase order to perform the initial phase of the contract which provides for the modification of an existing ion implanter that should enable the ion implantation of the customer’s specialty substrate. Following this initial phase, which is expected to be completed over the next several months, pilot production could then proceed over the remainder of the life of the contract.
